Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lein

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
European Urology|December 31, 2010
Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acidKlaus Jung, Kurt Miller, Manfred Wirth, et al.
Clinical Chemistry|April 1, 2008
Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9Klaus Jung, Silke Klotzek, Carsten Stephan, et al.
The Prostate|July 13, 2007
S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation studyStefan Ludwig, Carsten Stephan, Michael Lein, et al.
Cancer Letters|February 13, 2007
PSA and new biomarkers within multivariate models to improve early detection of prostate cancerCarsten Stephan, Henning Cammann, Hellmuth-A Meyer, et al.
The Prostate|December 29, 2006
Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancerAzizbek Ramankulov, Michael Lein, Glen Kristiansen, et al.
World Journal of Urology|January 20, 2021
PHI density prospectively improves prostate cancer detectionCarsten Stephan, Klaus Jung, Michael Lein, et al.
Clinical Biochemistry|February 18, 2014
Serum testosterone improves the accuracy of Prostate Health Index for the detection of prostate cancerFrank Friedersdorff, Philipp Manus, Kurt Miller, et al.
Cancer Science|April 22, 2008
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomasAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
Urology|July 3, 2003
Confocal laser scanning microscopy of urinary bladder after intravesical instillation of a fluorescent dyeFrank Koenig, Joachim Knittel, Ludger Schnieder, et al.
Oncology Reports|July 7, 2009
Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivoClaudia Abramjuk, Michael Bueschges, Jörg Schnorr, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
European Urology|December 31, 2010
Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acidKlaus Jung, Kurt Miller, Manfred Wirth, et al.
Clinical Chemistry|April 1, 2008
Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9Klaus Jung, Silke Klotzek, Carsten Stephan, et al.
The Prostate|July 13, 2007
S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation studyStefan Ludwig, Carsten Stephan, Michael Lein, et al.
Cancer Letters|February 13, 2007
PSA and new biomarkers within multivariate models to improve early detection of prostate cancerCarsten Stephan, Henning Cammann, Hellmuth-A Meyer, et al.
The Prostate|December 29, 2006
Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancerAzizbek Ramankulov, Michael Lein, Glen Kristiansen, et al.
World Journal of Urology|January 20, 2021
PHI density prospectively improves prostate cancer detectionCarsten Stephan, Klaus Jung, Michael Lein, et al.
Clinical Biochemistry|February 18, 2014
Serum testosterone improves the accuracy of Prostate Health Index for the detection of prostate cancerFrank Friedersdorff, Philipp Manus, Kurt Miller, et al.
Cancer Science|April 22, 2008
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomasAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
Urology|July 3, 2003
Confocal laser scanning microscopy of urinary bladder after intravesical instillation of a fluorescent dyeFrank Koenig, Joachim Knittel, Ludger Schnieder, et al.
Oncology Reports|July 7, 2009
Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivoClaudia Abramjuk, Michael Bueschges, Jörg Schnorr, et al.
Pageof 11